Minerva Neurosciences Inc (NERV)
2.40
+0.04
(+1.70%)
USD |
NASDAQ |
May 01, 16:00
2.33
-0.07
(-2.92%)
Pre-Market: 20:00
Minerva Neurosciences Market Cap: 16.78M for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 16.78M |
| April 30, 2024 | 16.50M |
| April 29, 2024 | 16.85M |
| April 26, 2024 | 17.04M |
| April 25, 2024 | 16.99M |
| April 24, 2024 | 17.62M |
| April 23, 2024 | 17.69M |
| April 22, 2024 | 17.83M |
| April 19, 2024 | 17.34M |
| April 18, 2024 | 17.48M |
| April 17, 2024 | 17.27M |
| April 16, 2024 | 17.48M |
| April 15, 2024 | 16.92M |
| April 12, 2024 | 17.48M |
| April 11, 2024 | 17.76M |
| April 10, 2024 | 17.27M |
| April 09, 2024 | 17.76M |
| April 08, 2024 | 17.76M |
| April 05, 2024 | 17.76M |
| April 04, 2024 | 17.69M |
| April 03, 2024 | 17.76M |
| April 02, 2024 | 17.59M |
| April 01, 2024 | 17.69M |
| March 28, 2024 | 18.04M |
| March 27, 2024 | 17.48M |
| Date | Value |
|---|---|
| March 26, 2024 | 17.97M |
| March 25, 2024 | 18.60M |
| March 22, 2024 | 18.67M |
| March 21, 2024 | 18.11M |
| March 20, 2024 | 18.88M |
| March 19, 2024 | 18.53M |
| March 18, 2024 | 18.88M |
| March 15, 2024 | 19.51M |
| March 14, 2024 | 19.23M |
| March 13, 2024 | 19.72M |
| March 12, 2024 | 19.37M |
| March 11, 2024 | 19.65M |
| March 08, 2024 | 19.58M |
| March 07, 2024 | 17.90M |
| March 06, 2024 | 18.18M |
| March 05, 2024 | 18.18M |
| March 04, 2024 | 18.04M |
| March 01, 2024 | 18.39M |
| February 29, 2024 | 18.67M |
| February 28, 2024 | 19.79M |
| February 27, 2024 | 19.58M |
| February 26, 2024 | 47.56M |
| February 23, 2024 | 48.04M |
| February 22, 2024 | 50.70M |
| February 21, 2024 | 61.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.636M
Minimum
Dec 28 2022
576.52M
Maximum
May 26 2020
108.68M
Average
68.05M
Median
Feb 12 2024
Market Cap Benchmarks
| Viking Therapeutics Inc | 8.428B |
| Janux Therapeutics Inc | 3.006B |
| ACADIA Pharmaceuticals Inc | 2.808B |
| Karyopharm Therapeutics Inc | 124.27M |
| Calidi Biotherapeutics Inc | 6.859M |
Market Cap Related Metrics
| Price | 2.40 |
| Earnings Yield | -194.2% |